Company Description

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight.

Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.

Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

Allurion Technologies Inc.

Country	United States
Founded	2009
Industry	Medical Devices
Sector	Healthcare
Employees	504
CEO	Shantanu Gaur

Contact Details

Address: 11 Huron Drive Natick, Massachusetts 01760 United States
Phone	508 647 4000
Website	allurion.com

Stock Details

Ticker Symbol	ALUR
Exchange	NYSE
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001964979
CUSIP Number	02008G102
ISIN Number	US02008G1022
SIC Code	3841

Key Executives

Name	Position
Dr. Shantanu K. Gaur M.D.	Co-Founder, Chief Executive Officer, President, Principal Financial and Accounting Officer and Director
Dr. Samuel G. Levy	Co-Founder
Dr. Ram Chuttani M.D.	MD, Chief Medical Officer and Founding Partner
Ojas A. Buch	Chief Operating Officer
Brendan Michael Gibbons J.D.	Chief Legal Officer and Corporate Secretary
Matt Wright	Vice President of People
Joyce Johnson	Senior Vice President of Regulatory Affairs and Quality Assurance
Adrian Wild	Senior Vice President of International Commercial

Latest SEC Filings

Date	Type	Title
Jan 29, 2025	SCHEDULE 13D/A	Filing
Jan 28, 2025	424B3	Prospectus
Jan 28, 2025	424B3	Prospectus
Jan 28, 2025	8-K	Current Report
Jan 27, 2025	424B5	Filing
Jan 17, 2025	424B3	Prospectus
Jan 17, 2025	424B3	Prospectus
Jan 17, 2025	8-K	Current Report
Jan 16, 2025	SCHEDULE 13D/A	Filing
Jan 14, 2025	RW	Filing

View All SEC Filings